Harmony Outcomes committees and investigators. Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial - Hernandez, A F; Green, J B; Janmohamed, S (Lancet, 2018)
et al.